消融设备市场规模、份额、成长分析（按技术、应用、最终用户和地区）- 2025 年至 2032 年产业预测

消融设备市场规模预计在 2023 年达到 94 亿美元，从 2024 年的 104.2 亿美元成长到 2032 年的 238.5 亿美元，在预测期内（2025-2032 年）的复合年增长率为 10.9%。

外科手术技术的最新进展反映了医疗保健领域的重大变革，特别是微创手术的兴起。随着世界人口老化和慢性疾病变得越来越复杂，患者正在寻求侵入性较小的治疗方法，以尽量减少术后压力。微创手术，包括汽化、冷冻疗法和射频等消融技术，具有减轻疼痛、缩短住院时间和加速恢復时间等好处。透过消融术去除肿瘤和进行组织治疗正获得越来越多的支持，因为它比传统手术侵入性更小。随着癌症和心血管疾病等慢性疾病变得越来越普遍，对消融设备的需求预计将飙升，凸显了患者照护和外科手术创新的重要趋势。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

消融设备市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 射频设备
• 雷射/光消融
• 超音波设备
• 冷冻消融装置
• 其他技术

消融设备市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概览
• 心臟病学
• 肿瘤学
• 眼科
• 妇科
• 泌尿系统
• 整容手术
• 其他用途

消融设备市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 门诊手术中心
• 其他最终用户

消融设备市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Johnson & Johnson（USA）
• AngioDynamics, Inc.（USA）
• AtriCure, Inc.（USA）
• Olympus Corporation（Japan）
• Smith & Nephew plc（UK）
• Stryker Corporation（USA）
• Avanos Medical, Inc.（USA）
• Hologic, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips NV（Netherlands）
• Baylis Medical Company, Inc.（Canada）
• Elekta AB（Sweden）
• Haifu Medical Technology Co., Ltd.（China）
• Apyx Medical（formerly Bovie Medical）（USA）
• LeMaitre Vascular, Inc.（USA）
• Alcon Laboratories, Inc.（USA）
• Biotronik SE & Co. KG（Germany）

结论和建议

Ablation Devices Market size was valued at USD 9.4 billion in 2023 and is poised to grow from USD 10.42 billion in 2024 to USD 23.85 billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

Recent advancements in surgical methods reflect a significant transformation within the healthcare sector, especially with the rise of minimally invasive surgery. As the global population ages and the complexity of chronic diseases increases, patients increasingly seek less disruptive treatment options that minimize post-surgical stress. Minimally invasive procedures, including ablation techniques-such as vaporization, freezing, and radiofrequency-offer benefits of reduced pain, shorter hospital stays, and faster recovery times. This shift toward ablation for tumor removal and tissue treatment has gained traction due to its less intrusive nature compared to traditional surgeries. As chronic conditions like cancer and cardiovascular disease become more prevalent, the demand for ablation devices is expected to surge, highlighting a critical trend in patient care and surgical innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Ablation Devices Market Segments Analysis

Global Ablation Devices Market is segmented by Technology, Application, End-user and region. Based on Technology, the market is segmented into Radiofrequency devices, Laser/light ablation, Ultrasound devices, Cryoablation devices and Other technologies. Based on Application, the market is segmented into Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic surgery and Other applications. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Ablation Devices Market

A significant factor driving the growth of the Ablation Devices market is the growing preference among patients for minimally invasive procedures instead of traditional open surgeries. In recent years, there has been a marked rise in the adoption and acceptance of minimally invasive therapies, largely due to their advantages, such as shorter hospital stays, quicker recovery times, and reduced discomfort when compared to conventional surgical methods. Additionally, the increasing prevalence of atrial fibrillation within the population is expected to lead to more cardiac ablation procedures. The ablation method for treating atrial fibrillation offers effective results with lower risks and enhanced convenience for patients. Consequently, the shift towards less invasive treatment options, combined with the increasing use of ablation devices, will significantly drive market growth in the coming years.

Restraints in the Ablation Devices Market

The Ablation Devices market faces substantial limitations due to the insufficient availability of effective conventional first-line medications for conditions like liver cancer, uterine fibroids, haemorrhagic stroke, and various haemorrhagic disorders. The dominant preference for therapies such as surgery, chemotherapy, and radiation is a major barrier, largely stemming from the high level of public awareness surrounding traditional cancer treatments. Additionally, the limited adoption of advanced treatment alternatives, especially in developing regions, coupled with oncologists' hesitance to move away from established treatment protocols, further exacerbates this issue. This resistance to embrace innovative solutions significantly hampers market growth.

Market Trends of the Ablation Devices Market

The Ablation Devices market is poised for significant growth in untapped regions such as Asia-Pacific, Africa, and Latin America, driven by advancements in ablation technologies and rising demand for minimally invasive therapies. Increasing disposable incomes in these areas further enhance market potential. Concurrently, the large undiagnosed patient population and rapid urbanization, which correlate with a rise in chronic illnesses, coupled with heightened awareness of conditions like prostate cancer, are catalysts for demand. Furthermore, augmented government funding for healthcare initiatives is anticipated to propel market expansion in these regions, making them increasingly attractive for industry stakeholders.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Ablation Devices Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency devices
• Laser/light ablation
• Ultrasound devices
• Cryoablation devices
• Other technologies

Global Ablation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Oncology
• Ophthalmology
• Gynecology
• Urology
• Cosmetic surgery
• Other applications

Global Ablation Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory surgical centers
• Other end users

Global Ablation Devices Market Size & CAGR (2025-2032)

• North America (Technology, Application, End-user)
  • US
  • Canada
• Europe (Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baylis Medical Company, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apyx Medical (formerly Bovie Medical) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations